tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Hong Kong Market
Advertisement

CanSino Biologics, Inc. Class H (6185) Ratios

Compare
4 Followers

CanSino Biologics, Inc. Class H Ratios

HK:6185's free cash flow for Q2 2025 was ¥0.78. For the 2025 fiscal year, HK:6185's free cash flow was decreased by ¥ and operating cash flow was ¥-0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.57 2.00 2.63 3.23 13.13
Quick Ratio
2.37 1.86 2.40 2.93 12.72
Cash Ratio
0.96 0.79 1.15 1.90 10.77
Solvency Ratio
<0.01 -0.30 -0.18 0.60 -0.48
Operating Cash Flow Ratio
0.06 -0.35 -0.64 0.70 -1.14
Short-Term Operating Cash Flow Coverage
0.10 -0.66 -1.20 1.86 -11.69
Net Current Asset Value
¥ 1.53B¥ 1.15B¥ 3.51B¥ 5.96B¥ 4.74B
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.29 0.24 0.12 0.02
Debt-to-Equity Ratio
0.39 0.51 0.40 0.17 0.02
Debt-to-Capital Ratio
0.28 0.34 0.29 0.15 0.02
Long-Term Debt-to-Capital Ratio
0.15 0.17 0.12 <0.01 0.01
Financial Leverage Ratio
1.57 1.77 1.70 1.49 1.11
Debt Service Coverage Ratio
-0.04 -1.12 -0.50 1.77 -9.05
Interest Coverage Ratio
-4.19 -31.73 -33.11 93.62 -3.15K
Debt to Market Cap
0.14 0.49 0.17 0.03 <0.01
Interest Debt Per Share
6.25 11.20 11.10 5.64 0.62
Net Debt to EBITDA
-6.57 -0.40 0.67 -2.06 10.68
Profitability Margins
Gross Profit Margin
74.54%-253.78%-18.10%69.85%25.56%
EBIT Margin
-25.19%-554.70%-110.83%45.52%-2138.90%
EBITDA Margin
-4.55%-476.76%-99.82%45.98%-2173.04%
Operating Profit Margin
-17.90%-589.60%-132.75%44.46%-2374.48%
Pretax Profit Margin
-18.52%-573.29%-114.84%45.04%-2138.90%
Net Profit Margin
-18.05%-429.55%-93.57%44.52%-1933.19%
Continuous Operations Profit Margin
-18.05%-569.97%-93.57%44.35%-2138.90%
Net Income Per EBT
97.48%74.93%81.48%98.84%90.38%
EBT Per EBIT
103.43%97.23%86.50%101.32%90.08%
Return on Assets (ROA)
-2.17%-15.91%-8.41%16.12%-5.31%
Return on Equity (ROE)
-3.35%-28.11%-14.30%23.94%-5.91%
Return on Capital Employed (ROCE)
-2.75%-30.25%-16.05%21.24%-6.95%
Return on Invested Capital (ROIC)
-2.30%-24.72%-10.99%18.62%-6.23%
Return on Tangible Assets
-2.22%-16.27%-8.61%16.40%-5.37%
Earnings Yield
-0.73%-29.34%-6.63%5.27%-1.05%
Efficiency Ratios
Receivables Turnover
1.40 0.00 1.21 27.23 0.84
Payables Turnover
5.09 11.75 4.81 1.54 0.23
Inventory Turnover
0.69 3.48 1.80 1.48 0.08
Fixed Asset Turnover
0.35 0.11 0.33 1.94 0.02
Asset Turnover
0.12 0.04 0.09 0.36 <0.01
Working Capital Turnover Ratio
0.35 0.09 0.18 0.75 <0.01
Cash Conversion Cycle
715.30 73.73 430.15 22.71 3.34K
Days of Sales Outstanding
260.49 0.00 302.85 13.41 435.84
Days of Inventory Outstanding
526.45 104.81 203.17 246.51 4.51K
Days of Payables Outstanding
71.65 31.08 75.87 237.21 1.60K
Operating Cycle
786.95 104.81 506.02 259.92 4.94K
Cash Flow Ratios
Operating Cash Flow Per Share
0.33 -3.71 -7.64 8.14 -2.04
Free Cash Flow Per Share
-0.73 -6.19 -11.99 3.28 -3.21
CapEx Per Share
1.07 2.47 4.35 4.86 1.17
Free Cash Flow to Operating Cash Flow
-2.21 1.67 1.57 0.40 1.58
Dividend Paid and CapEx Coverage Ratio
0.27 -1.49 -1.49 1.66 -1.69
Capital Expenditure Coverage Ratio
0.31 -1.50 -1.76 1.67 -1.73
Operating Cash Flow Coverage Ratio
0.05 -0.34 -0.70 1.47 -3.29
Operating Cash Flow to Sales Ratio
0.11 -2.65 -1.83 0.47 -25.31
Free Cash Flow Yield
-1.67%-30.21%-20.35%2.23%-2.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-137.21 -3.41 -15.09 18.97 -95.36
Price-to-Sales (P/S) Ratio
14.66 14.64 14.12 8.45 1.84K
Price-to-Book (P/B) Ratio
4.67 0.96 2.16 4.54 5.63
Price-to-Free Cash Flow (P/FCF) Ratio
-59.87 -3.31 -4.91 44.75 -46.18
Price-to-Operating Cash Flow Ratio
223.58 -5.52 -7.71 18.03 -72.83
Price-to-Earnings Growth (PEG) Ratio
-5.55 -0.06 0.10 -0.03 -0.89
Price-to-Fair Value
4.67 0.96 2.16 4.54 5.63
Enterprise Value Multiple
-328.69 -3.47 -13.47 16.30 -74.15
Enterprise Value
13.84B 5.71B 13.87B 32.23B 29.88B
EV to EBITDA
-328.69 -3.47 -13.47 16.30 -74.15
EV to Sales
14.96 16.53 13.45 7.50 1.61K
EV to Free Cash Flow
-61.09 -3.74 -4.68 39.72 -40.37
EV to Operating Cash Flow
135.02 -6.23 -7.35 16.00 -63.66
Tangible Book Value Per Share
15.25 20.59 28.28 33.74 26.01
Shareholders’ Equity Per Share
15.89 21.37 27.32 32.31 26.33
Tax and Other Ratios
Effective Tax Rate
0.03 <0.01 0.19 0.02 0.10
Revenue Per Share
3.00 1.40 4.17 17.38 0.08
Net Income Per Share
-0.54 -6.01 -3.91 7.74 -1.55
Tax Burden
0.97 0.75 0.81 0.99 0.90
Interest Burden
0.74 1.03 1.04 0.99 1.00
Research & Development to Revenue
0.41 1.85 0.75 0.20 23.11
SG&A to Revenue
0.18 0.85 0.27 0.05 4.47
Stock-Based Compensation to Revenue
<0.01 0.03 <0.01 <0.01 0.94
Income Quality
-0.61 0.62 1.59 1.06 1.15
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis